Elamipretide Hydrochloride

FDA Drug Profile — FORZINITY

Drug Details

Generic Name
Elamipretide Hydrochloride
Brand Names
FORZINITY
Application Number
NDA215244
Sponsor
Stealth Biotherapeutics Inc.
NDC Codes
1
Dosage Forms
INJECTION
Routes
SUBCUTANEOUS
Active Ingredients
ELAMIPRETIDE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE FORZINITY is indicated to improve muscle strength in adult and pediatric patients with Barth syndrome weighing at least 30 kg. This indication is approved under accelerated approval based on an improvement in knee extensor muscle strength, an intermediate clinical endpoint [see Clinical Studies (14) ] . Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. FORZINITY™ is a mitochondrial cardiolipin binder indicated to improve muscle strength in adult and pediatric patients with Barth syndrome weighing at least 30 kg. ( 1 ) This indication is approved under accelerated approval based on an improvement in knee extensor muscle strength, an intermediate clinical endpoint. ( 14 ) Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).